Search
Achieve Life Sciences Inc
ACHVAdd to Watchlist
6.490USD
-0.010-0.15%
Close 10-23 16:00（ET）
667.82MMarket Cap
LossP/E TTM
Achieve Life Sciences Inc (ACHV) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Achieve Life Sciences Inc in the past month.
Buy
2 Strong Buy
10 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
14.154USD+121.85%
ACHV Analyst Recommendation Trends
In the current month, ACHV has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ACHV average Analyst price target in the last month is 14.154.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2
2
1
1
0
0
0
0
10
10
8
8
8
8
7
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
9
9
8
8
7
7
ACHV Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Biontech SE
BNTX
4
12
8
0
0
24
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Cytokinetics Inc
CYTK
5
16
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Financial Forecasting
Based on analysts' estimates, ACHV EPS is projected to reach -0.200 in FY2026Q3, following reported EPS of -0.800 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.27
-0.31
-0.16
-0.20
-0.21
Actual
-0.27
-0.19
-0.80
--
--
Surprise
-0.38%
+38.22%
-415.53%
--
--
FAQs
What is Achieve Life Sciences Inc's price target?
Analysts forecast that Achieve Life Sciences Inc's price target is USD 14.15, with the highest forecast at USD 21.00 and the lowest forecast at USD 9.00.
How have Achieve Life Sciences IncACHV's recent earnings per share performed?
The market expectation was USD -0.80, while Achieve Life Sciences IncACHV's earnings per share (EPS) for the previous quarter was USD -0.19. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for Achieve Life Sciences Inc?
Based on the ratings of Achieve Life Sciences Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.